Xconomy’s Digital Events →
Steve Harr, Juno Therapeutics chief financial officer
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Sponsored · Special Report
Hyperinflation in rents is over